Cargando…
Characterisation of bioenergetic pathways and related regulators by multiple assays in human tumour cells
BACKGROUND: Alterations in cellular metabolism are considered as hallmarks of cancers, however, to recognize these alterations and understand their mechanisms appropriate techniques are required. Our hypothesis was to determine whether dominant bioenergetic mechanism may be estimated by comparing th...
Autores principales: | Jeney, A., Hujber, Z., Szoboszlai, N., Fullár, A., Oláh, J., Pap, É., Márk, Á., Kriston, Cs., Kralovánszky, J., Kovalszky, I., Vékey, K., Sebestyén, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4750284/ https://www.ncbi.nlm.nih.gov/pubmed/26869854 http://dx.doi.org/10.1186/s12935-016-0281-x |
Ejemplares similares
-
Targeting cellular metabolism using rapamycin and/or doxycycline enhances anti-tumour effects in human glioma cells
por: Petővári, Gábor, et al.
Publicado: (2018) -
Rapamycin (mTORC1 inhibitor) reduces the production of lactate and 2-hydroxyglutarate oncometabolites in IDH1 mutant fibrosarcoma cells
por: Hujber, Zoltán, et al.
Publicado: (2017) -
GABA, glutamine, glutamate oxidation and succinic semialdehyde dehydrogenase expression in human gliomas
por: Hujber, Zoltán, et al.
Publicado: (2018) -
Characterisation of Walker 256 breast carcinoma cells from two tumour cell banks as assessed using two models of secondary brain tumours
por: Lewis, Kate M, et al.
Publicado: (2013) -
Activation of synovial fibroblasts in rheumatoid arthritis: lack of
expression of the tumour suppressor PTEN at sites of invasive growth and
destruction
por: Pap, Thomas, et al.
Publicado: (2000)